BPC-157 is an FDA advisory board approved peptide therapy that offers an effective, targeted approach for joint and soft tissue recovery
Lower insulin requirements are also noted in real-world studies (50, 51)
The brain, in particular, due to its higher oxygen consumption and weaker antioxidant defense, is more vulnerable to oxidative stress
Zhao RZ, Jiang S, Zhang L, Yu ZB
IV therapy can complement a healthy lifestyle by addressing specific nutrient deficiencies or providing additional support
Once reconstituted, both compounds require refrigeration and have finite use windows before potency declines